메뉴 건너뛰기




Volumn 30, Issue 3, 2006, Pages 44-50

Probiotics in inflammatory bowel disease

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LYSATE; MESALAZINE; PROBIOTIC AGENT; UNCLASSIFIED DRUG; VSL NUMBER 3;

EID: 33645781483     PISSN: 02774208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (1)

References (42)
  • 1
    • 0037425743 scopus 로고    scopus 로고
    • Gut flora in health and disease
    • See comment
    • Guarner F, Malagelada JR. Gut flora in health and disease. [See comment]. Lancet, 2003;361(9356):512-519.
    • (2003) Lancet , vol.361 , Issue.9356 , pp. 512-519
    • Guarner, F.1    Malagelada, J.R.2
  • 2
    • 2442453484 scopus 로고    scopus 로고
    • Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: Antibiotics, probiotics, and prebiotics
    • Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology, 2004;126(6):1620-1633.
    • (2004) Gastroenterology , vol.126 , Issue.6 , pp. 1620-1633
    • Sartor, R.B.1
  • 4
    • 0346092494 scopus 로고    scopus 로고
    • Probiotics: What are they? What are their effects on gut physiology?
    • Fioramonti J, Theodorou V, Bueno L. Probiotics: what are they? What are their effects on gut physiology? Best Pract Res Clin Gastroenterol, 2003;17(5):711-724.
    • (2003) Best Pract Res Clin Gastroenterol , vol.17 , Issue.5 , pp. 711-724
    • Fioramonti, J.1    Theodorou, V.2    Bueno, L.3
  • 5
    • 0029586031 scopus 로고
    • Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)
    • Duchmann R, Kaiser I, Hermann E, et al. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 1995;102:448-455.
    • (1995) Clin Exp Immunol , vol.102 , pp. 448-455
    • Duchmann, R.1    Kaiser, I.2    Hermann, E.3
  • 6
    • 0029866466 scopus 로고    scopus 로고
    • Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria
    • MacPherson A, Khoo UY, Forgacs I, et al. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut, 1996;38:365-375.
    • (1996) Gut , vol.38 , pp. 365-375
    • MacPherson, A.1    Khoo, U.Y.2    Forgacs, I.3
  • 7
    • 2442524857 scopus 로고    scopus 로고
    • Microbial influences in inflammatory bowel disease: Role in pathogenesis and clinical implications
    • Sartor RB and Sandborn WJ, eds. Edinburgh: Elsevier
    • Sartor RB. Microbial influences in inflammatory bowel disease: role in pathogenesis and clinical implications. In: Sartor RB and Sandborn WJ, eds. Kirsner's Inflammatory Bowel Diseases. 6th ed. Edinburgh: Elsevier; 2003:138-162.
    • (2003) Kirsner's Inflammatory Bowel Diseases. 6th Ed. , pp. 138-162
    • Sartor, R.B.1
  • 8
    • 0036117798 scopus 로고    scopus 로고
    • Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease
    • Neut C, Bulois P, Desreumaux P, et al. Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease. Am J Gastroenterol, 2002;97:939-946.
    • (2002) Am J Gastroenterol , vol.97 , pp. 939-946
    • Neut, C.1    Bulois, P.2    Desreumaux, P.3
  • 10
    • 0027563343 scopus 로고
    • An immunocytochemical search for infectious agents in Crohn's disease
    • Cartun RW, Van Kruiningen HJ, Pedersen CA, et al. An immunocytochemical search for infectious agents in Crohn's disease. Mod Path, 1993;6:212-219.
    • (1993) Mod Path , vol.6 , pp. 212-219
    • Cartun, R.W.1    Van Kruiningen, H.J.2    Pedersen, C.A.3
  • 11
    • 0034183435 scopus 로고    scopus 로고
    • Probiotics and inflammatory bowel disease: Is there a scientific rationale?
    • Shanahan F. Probiotics and inflammatory bowel disease: Is there a scientific rationale? Inflamm Bowel Dis, 2000;6:107-115.
    • (2000) Inflamm Bowel Dis , vol.6 , pp. 107-115
    • Shanahan, F.1
  • 12
    • 0031915148 scopus 로고    scopus 로고
    • Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum
    • D'Haens G, Geboes K, Peeters M, et al. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology, 1998;114:262-267.
    • (1998) Gastroenterology , vol.114 , pp. 262-267
    • D'Haens, G.1    Geboes, K.2    Peeters, M.3
  • 13
    • 20244388832 scopus 로고    scopus 로고
    • Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: A randomized, double-blind, placebo-controlled trial
    • Rutgeerts P, Van Assche G, Vermeire S, et al. Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology, 2005;128(4):856-861.
    • (2005) Gastroenterology , vol.128 , Issue.4 , pp. 856-861
    • Rutgeerts, P.1    Van Assche, G.2    Vermeire, S.3
  • 14
    • 2542574746 scopus 로고    scopus 로고
    • Mutations in the NOD2/CARD15 gene in Crohn's disease are associated with ileocecal resection and are a risk factor for reoperation
    • Buning C, Genschel S, Buhner S, et al. Mutations in the NOD2/CARD15 gene in Crohn's disease are associated with ileocecal resection and are a risk factor for reoperation. Aliment Pharmacol Ther, 2004;19:1073-1078.
    • (2004) Aliment Pharmacol Ther , vol.19 , pp. 1073-1078
    • Buning, C.1    Genschel, S.2    Buhner, S.3
  • 15
    • 0036716855 scopus 로고    scopus 로고
    • Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: A randomized controlled trial with Lactobacillus GG
    • Prantera C, Scribano ML, Falasco G, et al. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomized controlled trial with Lactobacillus GG. Gut, 2002;51:405-409.
    • (2002) Gut , vol.51 , pp. 405-409
    • Prantera, C.1    Scribano, M.L.2    Falasco, G.3
  • 16
    • 0031443860 scopus 로고    scopus 로고
    • Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease?
    • Malchow H. Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease? J Clin Gastroenterol, 1997;25(4):653-658.
    • (1997) J Clin Gastroenterol , vol.25 , Issue.4 , pp. 653-658
    • Malchow, H.1
  • 17
    • 0033870413 scopus 로고    scopus 로고
    • Saccharomyces boulardii in maintenance treatment of Crohn's disease
    • Guslandi M, Mezzi G, Sorghi M, et al. Saccharomyces boulardii in maintenance treatment of Crohn's disease. Dig Dis Sci, 2000;45(7):1462-1464.
    • (2000) Dig Dis Sci , vol.45 , Issue.7 , pp. 1462-1464
    • Guslandi, M.1    Mezzi, G.2    Sorghi, M.3
  • 18
    • 0032815979 scopus 로고    scopus 로고
    • Inpact on the composition of the fecal flora by a new probiotic preparation: Preliminary data on the maintenance treatment of patients with ulcerative colitis
    • Venturi A, Gionchetti P, Rizzello F, et al. Inpact on the composition of the fecal flora by a new probiotic preparation: preliminary data on the maintenance treatment of patients with ulcerative colitis. Aliment Pharmacol Ther, 1999;13:1103-1108.
    • (1999) Aliment Pharmacol Ther , vol.13 , pp. 1103-1108
    • Venturi, A.1    Gionchetti, P.2    Rizzello, F.3
  • 19
    • 0033592203 scopus 로고    scopus 로고
    • Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: A randomized trial
    • Rembacken BJ, Snelling AM, Hawkey PM, et al. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomized trial. Lancet, 1999;354:635-639.
    • (1999) Lancet , vol.354 , pp. 635-639
    • Rembacken, B.J.1    Snelling, A.M.2    Hawkey, P.M.3
  • 20
    • 0000226162 scopus 로고    scopus 로고
    • Maintenance of remission in ulcerative colitis is equally effective with Escherichia coli Nissle 1917 and with standard mesalamine
    • Kruis W, Kalk EK, Fric P, et al. Maintenance of remission in ulcerative colitis is equally effective with Escherichia coli Nissle 1917 and with standard mesalamine (abstr). Gastroenterology, 2001;120:A127.
    • (2001) Gastroenterology , vol.120
    • Kruis, W.1    Kalk, E.K.2    Fric, P.3
  • 21
    • 0023521441 scopus 로고
    • Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis - A randomized study
    • Schroeder K, Tremaine W, Sandborn W, Ilstrup D. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis-a randomized study. N Eng J Med, 1987;317:1625-1629.
    • (1987) N Eng J Med , vol.317 , pp. 1625-1629
    • Schroeder, K.1    Tremaine, W.2    Sandborn, W.3    Ilstrup, D.4
  • 22
    • 75549096111 scopus 로고
    • Variation in observers in describing mucosal appearances in proctocolitis
    • Baron J, Connell A, Lennard-Jones J. Variation in observers in describing mucosal appearances in proctocolitis. BMJ 1964;i:89-92.
    • (1964) BMJ , vol.1 , pp. 89-92
    • Baron, J.1    Connell, A.2    Lennard-Jones, J.3
  • 23
    • 0038063405 scopus 로고    scopus 로고
    • VSL3 probiotic mixture induces remission in patients with active ulcerative colitis
    • Fedorak RN, Gionchetti P, Campieri M, et al. VSL3 probiotic mixture induces remission in patients with active ulcerative colitis (abstr). Gastroenterology, 2003;124:A377.
    • (2003) Gastroenterology , vol.124
    • Fedorak, R.N.1    Gionchetti, P.2    Campieri, M.3
  • 24
  • 25
    • 0033860601 scopus 로고    scopus 로고
    • Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial
    • Gionchetti P, Rizzelo F, Venturi A, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology, 2000;119:305-309.
    • (2000) Gastroenterology , vol.119 , pp. 305-309
    • Gionchetti, P.1    Rizzelo, F.2    Venturi, A.3
  • 26
    • 0001284907 scopus 로고    scopus 로고
    • Once daily high dose probiotic therapy maintains remission and improved quality of life in patients with recurrent or refractory pouchitis: A randomized, placebo-controlled, double-blind trial
    • Mimura T, Rizzello F, Schreiber S, et al. Once daily high dose probiotic therapy maintains remission and improved quality of life in patients with recurrent or refractory pouchitis: a randomized, placebo-controlled, double-blind trial (abst). Gastroenterology, 2002;122:A81.
    • (2002) Gastroenterology , vol.122
    • Mimura, T.1    Rizzello, F.2    Schreiber, S.3
  • 27
    • 0028345875 scopus 로고
    • Pouchitis after ileal pouch-anal anastamosis: A pouchitis disease activity index
    • Sandborn WJ, Tremaine WJ, Batts KP, et al. Pouchitis after ileal pouch-anal anastamosis: a pouchitis disease activity index. Mayo Clinic Proc, 1994;69:409-415.
    • (1994) Mayo Clinic Proc , vol.69 , pp. 409-415
    • Sandborn, W.J.1    Tremaine, W.J.2    Batts, K.P.3
  • 28
    • 0038185270 scopus 로고    scopus 로고
    • Prophylaxis of pouchitis onset with probiotic therapy: A double-blind placebo controlled trial
    • Gionchetti P, Rizzelo F, Helwig U, et al. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind placebo controlled trial. Gastroenterology, 2003;124:1202-1209.
    • (2003) Gastroenterology , vol.124 , pp. 1202-1209
    • Gionchetti, P.1    Rizzelo, F.2    Helwig, U.3
  • 29
    • 33645777914 scopus 로고    scopus 로고
    • An open-labeled trial of probiotic as a maintenance therapy in patients with antibiotic-dependent pouchitis
    • Shen B, Fazio V, Remzi F, et al. An open-labeled trial of probiotic as a maintenance therapy in patients with antibiotic-dependent pouchitis. Gastroenterology, 2005;124:A586.
    • (2005) Gastroenterology , vol.124
    • Shen, B.1    Fazio, V.2    Remzi, F.3
  • 30
    • 0035055766 scopus 로고    scopus 로고
    • Long-term follow-up after ileoanal pouch procedure: Algorithm for diagnosis, classification and management of pouchitis
    • Heuschen UA, Autschbach F, Allemeyer EH, et al. Long-term follow-up after ileoanal pouch procedure: algorithm for diagnosis, classification and management of pouchitis. Dis Colon Rectum, 2001;44:487-499.
    • (2001) Dis Colon Rectum , vol.44 , pp. 487-499
    • Heuschen, U.A.1    Autschbach, F.2    Allemeyer, E.H.3
  • 31
    • 0034898590 scopus 로고    scopus 로고
    • Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis
    • Shen B, Achkar JP, Lashner BA, et al. Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis. Gastroenterology, 2001;121:261-267.
    • (2001) Gastroenterology , vol.121 , pp. 261-267
    • Shen, B.1    Achkar, J.P.2    Lashner, B.A.3
  • 33
    • 0002613273 scopus 로고    scopus 로고
    • Safety of probiotic bacteria
    • Salminen S, Von Wright A, eds. New York: Marcel Decker
    • Donohue DC, Salminen S, Marteau P. Safety of probiotic bacteria. In: Salminen S, Von Wright A, eds. Lactic Acid Bacteria. New York: Marcel Decker; 1998:369-384.
    • (1998) Lactic Acid Bacteria , pp. 369-384
    • Donohue, D.C.1    Salminen, S.2    Marteau, P.3
  • 34
    • 0034890663 scopus 로고    scopus 로고
    • Lactibacillus casei subsp. rhamnosus sepsis in a patient with ulcerative colitis
    • Farina C, Arosio M, Mangia M, Moioli F. Lactibacillus casei subsp. rhamnosus sepsis in a patient with ulcerative colitis. J Clin Gastroenterol, 2001;33:251-252.
    • (2001) J Clin Gastroenterol , vol.33 , pp. 251-252
    • Farina, C.1    Arosio, M.2    Mangia, M.3    Moioli, F.4
  • 35
    • 0029028825 scopus 로고
    • Fungicemia with Saccharomyces boulardii in a 1-year-old girl with protracted diarrhea
    • Pletinex M, Legein J, Vandeplas Y. Fungicemia with Saccharomyces boulardii in a 1-year-old girl with protracted diarrhea. J Pediatr Gastroenterol Nutr, 1995;21:113-115.
    • (1995) J Pediatr Gastroenterol Nutr , vol.21 , pp. 113-115
    • Pletinex, M.1    Legein, J.2    Vandeplas, Y.3
  • 36
    • 2442495410 scopus 로고    scopus 로고
    • Probiotics and the management of inflammatory bowel disease
    • Fedorak RN, Madsen KL. Probiotics and the management of inflammatory bowel disease. Inflamm Bowel Dis, 2004;10(3):286-299.
    • (2004) Inflamm Bowel Dis , vol.10 , Issue.3 , pp. 286-299
    • Fedorak, R.N.1    Madsen, K.L.2
  • 37
    • 0037215109 scopus 로고    scopus 로고
    • Saccharomyses cerevaciae fungemia after Saccharomyses boulardii treatment in immunocompromised patients
    • Riquelme AJ, Calvo MA, Guzman AM, et al. Saccharomyses cerevaciae fungemia after Saccharomyses boulardii treatment in immunocompromised patients. J Clin Gastroenterol, 2003;36(1):41-43.
    • (2003) J Clin Gastroenterol , vol.36 , Issue.1 , pp. 41-43
    • Riquelme, A.J.1    Calvo, M.A.2    Guzman, A.M.3
  • 38
    • 0032954103 scopus 로고    scopus 로고
    • Liver abcess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG
    • Rautio M, Jousimies-Somer H, Kauma H, et al. Liver abcess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. Clin Infect Dis, 1999;28:1159-1160.
    • (1999) Clin Infect Dis , vol.28 , pp. 1159-1160
    • Rautio, M.1    Jousimies-Somer, H.2    Kauma, H.3
  • 40
    • 0033044663 scopus 로고    scopus 로고
    • Public health issues arising from microbiological and labelling quality foods and supplements containing probiotic organisms
    • Hamilton-Miller JMT, Shah S, Winkler JT. Public health issues arising from microbiological and labelling quality foods and supplements containing probiotic organisms. Public Health Nutr, 1999;2:223-229.
    • (1999) Public Health Nutr , vol.2 , pp. 223-229
    • Hamilton-Miller, J.M.T.1    Shah, S.2    Winkler, J.T.3
  • 41
    • 0037747750 scopus 로고    scopus 로고
    • Commercially available probiotic preparations: Are you getting what you pay for?
    • Katz JA, Pirovano F, Matteuzzi D, et al. Commercially available probiotic preparations: are you getting what you pay for? Gastroenterology, 2002;122(4):A459.
    • (2002) Gastroenterology , vol.122 , Issue.4
    • Katz, J.A.1    Pirovano, F.2    Matteuzzi, D.3
  • 42
    • 0034714188 scopus 로고    scopus 로고
    • Treatment of murine colitis by lactococcus lactis secreting interleukin-10
    • Steidler L, Hans W, Schotte L, et al. Treatment of murine colitis by lactococcus lactis secreting interleukin-10. Science, 2000;289:1352-1355.
    • (2000) Science , vol.289 , pp. 1352-1355
    • Steidler, L.1    Hans, W.2    Schotte, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.